Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | aristolochic acid A | increases expression | EXP | | 6480464 | aristolochic acid I results in increased expression of TAF1A-AS1 mRNA | CTD | PMID:33212167 | cyclosporin A | increases expression | EXP | | 6480464 | Cyclosporine results in increased expression of TAF1A-AS1 mRNA | CTD | PMID:27989131 | lipopolysaccharide | multiple interactions | EXP | | 6480464 | [S-(1 and 2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of TAF1A-AS1 mRNA | CTD | PMID:35811015 | S-(1,2-dichlorovinyl)-L-cysteine | multiple interactions | EXP | | 6480464 | [S-(1 and 2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of TAF1A-AS1 mRNA | CTD | PMID:35811015 | sodium dodecyl sulfate | increases expression | EXP | | 6480464 | Sodium Dodecyl Sulfate results in increased expression of TAF1A-AS1 mRNA | CTD | PMID:31734321 | valproic acid | increases expression | EXP | | 6480464 | Valproic Acid results in increased expression of TAF1A-AS1 mRNA | CTD | PMID:29154799 | vorinostat | increases expression | EXP | | 6480464 | vorinostat results in increased expression of TAF1A-AS1 mRNA | CTD | PMID:27188386 | |